RNA-binding protein FXR1 drives cMYC translation by recruiting eIF4F complex to the translation start site

Niclosamide’s potential direct targets in ovarian cancer†

(2021) Nikola Sekulovski et al.   BIOLOGY OF REPRODUCTION

The RNA-binding protein FXR1 modulates prostate cancer progression by regulating FBXO4

(2019) Hongwen Cao et al.   FUNCTIONAL & INTEGRATIVE GENOMICS

miRNA551b-3p Activates an Oncostatin Signaling Module for the Progression of Triple-Negative Breast Cancer

(2019) Deepak Parashar et al.   Cell Reports

Fragile X-related protein 1 (FXR1) regulates cyclooxygenase-2 (COX-2) expression at the maternal?fetal interface

(2018) Xiao-Cui Li et al.   REPRODUCTION FERTILITY AND DEVELOPMENT

A widespread alternate form of cap-dependent mRNA translation initiation

(2018) Columba de la Parra et al.   Nature Communications

Direct Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian Cancer

(2016) Pradeep Chaluvally-Raghavan et al.   Cell Reports

RNA-Binding Protein FXR1 Regulates p21 and TERC RNA to Bypass p53-Mediated Cellular Senescence in OSCC

(2016) Mrinmoyee Majumder et al.   PLoS Genetics

Clinical and prognostic significance of 3q26.2 and other chromosome 3 abnormalities in CML in the era of tyrosine kinase inhibitors

(2015) W. Wang et al.   BLOOD

The RNA binding protein FXR1 is a new driver in the 3q26-29 amplicon and predicts poor prognosis in human cancers

(2015) Jun Qian et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The Molecular Signatures Database Hallmark Gene Set Collection

(2015) Arthur Liberzon et al.   Cell Systems

Copy Number Gain of hsa-miR-569 at 3q26.2 Leads to Loss of TP53INP1 and Aggressiveness of Epithelial Cancers

(2014) Pradeep Chaluvally-Raghavan et al.   CANCER CELL

Hematogenous Metastasis of Ovarian Cancer: Rethinking Mode of Spread

(2014) Sunila Pradeep et al.   CANCER CELL

Inactivation of MYC reverses tumorigenesis

(2014) Y. Li et al.   JOURNAL OF INTERNAL MEDICINE

The interaction of cytoplasmic poly(A)-binding protein with eukaryotic initiation factor 4G suppresses nonsense-mediated mRNA decay

(2014) Tobias Fatscher et al.   RNA

MYC Activation Is a Hallmark of Cancer Initiation and Maintenance

(2014) M. Gabay et al.   Cold Spring Harbor Perspectives in Medicine

Translational Control in Cancer Etiology

(2012) D. Ruggero   Cold Spring Harbor Perspectives in Biology

Integrated genomic analyses of ovarian carcinoma

(2011) D. Bell et al.   NATURE

A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers

(2010) Bryan T. Hennessy et al.   Clinical Proteomics

SUnSET, a nonradioactive method to monitor protein synthesis

(2009) Enrico K Schmidt et al.   NATURE METHODS

Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome

(2008) R. W. Tothill et al.   CLINICAL CANCER RESEARCH

RNA-binding proteins and post-transcriptional gene regulation

(2008) Tina Glisovic et al.   FEBS LETTERS